BamSEC and AlphaSense Join Forces
Learn More

Xenetic Biosciences Inc.

NASDAQ: XBIO    
Share price (1/8/25): $4.08    
Market cap (1/8/25): $6.287 million

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2
from SC 13D/A 1 page The Undersigned, Being a Proposed Nominee as Defined in the Letter to Which This Exhibit Is Attached, Consents to Being Named in a Proxy Statement as a Nominee for Election to the Board at the Annual Meeting and to Serving as a Director on the Board, if Elected. /S/ M. Scott Maguire Name: M. Scott Maguire
12/34/56
EX-2.1
from 8-K 2 pages Third Amendment to Share Purchase Agreement
12/34/56
EX-2.1
from 8-K 2 pages Second Amendment to Share Purchase Agreement
12/34/56
EX-2.1
from 8-K 3 pages First Amendment to Share Purchase Agreement
12/34/56
EX-2.1
from 425 3 pages First Amendment to Share Purchase Agreement
12/34/56
EX-2.1
from 8-K/A 99 pages Share Purchase Agreement Between Xenetic Biosciences, Inc., Hesperix SA, Sellers Set Forth on the Signature Page Hereto. and Alexey Andreevich Vinogradov, as Representative of Sellers Dated as of March 1, 2019
12/34/56
EX-2.1
from 425 99 pages Share Purchase Agreement Between Xenetic Biosciences, Inc., Hesperix SA, Sellers Set Forth on the Signature Page Hereto. and Alexey Andreevich Vinogradov, as Representative of Sellers Dated as of March 1, 2019
12/34/56
EX-2.2
from 425 43 pages Assignment Agreement Between Xenetic Biosciences, Inc., and Opko Pharmaceuticals, LLC Dated as of March 1, 2019
12/34/56
EX-2.2
from 8-K 43 pages Assignment Agreement Between Xenetic Biosciences, Inc., and Opko Pharmaceuticals, LLC Dated as of March 1, 2019
12/34/56
EX-2.1
from 425 99 pages Share Purchase Agreement Between Xenetic Biosciences, Inc., Hesperix SA, Sellers Set Forth on the Signature Page Hereto. and Alexey Andreevich Vinogradov, as Representative of Sellers Dated as of March 1, 2019
12/34/56
EX-2.1
from 8-K 99 pages Share Purchase Agreement Between Xenetic Biosciences, Inc., Hesperix SA, Sellers Set Forth on the Signature Page Hereto. and Alexey Andreevich Vinogradov, as Representative of Sellers Dated as of March 1, 2019
12/34/56
EX-2.1
from 8-K 14 pages In the Matter of Xenetic Biosciences PLC and in the Matter of the Companies Act 2006 Order
12/34/56